Vantage Reports
Drawing on Evaluate data, Vantage reports provide an in-depth view on trends in the biotech, pharma and medtech sectors. Our special reports also provide a detailed look at some of the industry's hottest topics.
PD(L)anner - December 2021
In this special report, we provide you with the latest Evaluate Vantage update on clinical and regulatory developments in the PD-(L)1 inhibitor space. Among other issues,…
ASH 2022 Conference Round Up
This article pack, produced by Evaluate Vantage’s team of award-winning journalists, presents expert analysis and insights on data recently presented at the 63rd annual…
ASH 2022 Conference Round Up 英語版
This article pack, produced by Evaluate Vantage’s team of award-winning journalists, presents expert analysis and insights on data recently presented at the 63rd annual…
Infographic: Evaluate Vantage 2022 Preview 英語版
Leading up to the publication of the Evaluate Vantage 2022 Preview, we created this Infographic to provide a snapshot of the products and companies that are driving top…
Investor Interviews: Evaluate Vantage 2022 Preview
After a bruising 2021, biotech investors are hoping for a rebound. We interviewed investors and biopharma participants from across the sector, asking them to share their…
Investor Interviews: Evaluate Vantage 2022 Preview 英語版
After a bruising 2021, biotech investors are hoping for a rebound. We interviewed investors and biopharma participants from across the sector, asking them to share their…
Infographic: Evaluate Vantage 2022 Preview
Leading up to the publication of the Evaluate Vantage 2022 Preview, we created this Infographic to provide a snapshot of the products and companies that are driving top…
Evaluate Vantage 2022 Preview Report
Covid-19 will still be a front-page story in 2022, keeping the biopharma sector in the spotlight. The attention will bring some benefits, largely in the shape of broad…
Evaluate Vantage 2022 Preview Report 英語版
Covid-19 will still be a front-page story in 2022, keeping the biopharma sector in the spotlight. The attention will bring some benefits, largely in the shape of broad…
バイオファーマ考察記事まとめ (Q3 2021) 英語版
This article pack, produced by the editorial team at Evaluate Vantage, explores the key developments and decisions that are impacting the biopharma landscape. Access…
